Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K., Ghrelin Is a GrowthHormoneReleasing Acylated Peptide From Stomach, Nature 402, no
A 28-day phase 1b MAD study in participants with overweight or obesity demonstrates safety and tolerability at daily doses of 30 mg, 60 mg, and 90 mg with mean weight loss of 1.6%, 5.2%, and 5.4%, respectively, compared to 0.5% for placebo (49)
It is available as once-weekly subcutaneous semaglutide and oral semaglutide formulations for selected indications
For example, in the baseline of the placebo group there was an increase in the total number of ABR genes for the class of aminoglycosides of 86 to 157 in the antibiotic + supplement which subsequently decreased to 92 in the supplement-only and stabilized at 91 genes after washout